EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Heterogeneous blood pressure treatment effects on cognitive decline in type 2 diabetes: A machine learning analysis of a randomized clinical trial

Xuan Zhao, Xiaoli Xu, Siyu Wang, Xiaoyun Zhang, Ruizhi Zheng, Kan Wang, Yu Xiang, Tiange Wang iD, Zhiyun Zhao, Mian Li iD, Jie Zheng, Min Xu iD und 3 weitere

Diabetes, Obesity and Metabolism · 2025

DOI: 10.1111/dom.16145 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Xuan Zhao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Machine Learning, Cognitive Dysfunction, Hypertension. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: The Shanghai Municipal Government, The National Top Young Talents program, The National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim We aimed to identify the characteristics of patients with diabetes who can derive cognitive benefits from intensive blood pressure (BP) treatment using machine learning methods. Materials and Methods Using data from the Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes (ACCORD‐MIND) study, 1349 patients with type 2 diabetes who underwent BP treatment (intensive treatment targeting a systolic BP

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Machine LearningCognitive DysfunctionHypertensionAntihypertensive AgentsHumansMaleFemaleMiddle AgedAgedBlood PressureAlbuminuria

Stichwörter der Autor:innen

blood pressurecognitive declineheterogeneous treatment effectsmachine learningtype 2 diabetes

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • National Clinical Research Center for Metabolic Diseases (Shanghai), Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, National Research Center for Translational Medi…

ORCID-Profile: Tiange Wang, Mian Li, Min Xu, Jieli Lu, Yu Xu

Förderung

  • The Shanghai Municipal Government
  • The National Top Young Talents program
  • The National Natural Science Foundation of China
  • The Shanghai Clinical Research Center for Metabolic Diseases
  • The National Key R&D Program of China
  • The Innovative Research Team of High-Level Local Universities in Shanghai

Zitieren

APA

Zhao, X., Xu, X., Wang, S., Zhang, X., Zheng, R., Wang, K., Xiang, Y., Wang, T., Zhao, Z., Li, M., Zheng, J., Xu, M., Lu, J., Bi, Y., & Xu, Y. (2025). Heterogeneous blood pressure treatment effects on cognitive decline in type 2 diabetes: A machine learning analysis of a randomized clinical trial. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16145

Vancouver

Zhao X, Xu X, Wang S, Zhang X, Zheng R, Wang K, et al. Heterogeneous blood pressure treatment effects on cognitive decline in type 2 diabetes: A machine learning analysis of a randomized clinical trial. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16145

BibTeX
@article{Zhao2025,
  author = {Zhao, Xuan and Xu, Xiaoli and Wang, Siyu and Zhang, Xiaoyun and Zheng, Ruizhi and Wang, Kan and Xiang, Yu and Wang, Tiange and Zhao, Zhiyun and Li, Mian and Zheng, Jie and Xu, Min and Lu, Jieli and Bi, Yufang and Xu, Yu},
  title = {Heterogeneous blood pressure treatment effects on cognitive decline in type 2 diabetes: A machine learning analysis of a randomized clinical trial},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  doi = {10.1111/dom.16145}
}
Kostenlos starten →